The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126789262 12678926 2 F 20160830 20160824 20160906 EXP RU-ROCHE-1819057 ROCHE , LORIE Y, ZVONKOV E, GEMDJIAN E, MAGOMEDOVA A, MELIKYAN A, MANGASAROVA J, GRIBANOVA E, ZHEREBTSOVA V, KRAVCHENKO S AND SAVCHENKO V INTENSIVE INDUCTION, AUTOLOGOUS STEM CELL TRANSPLANTATION AND RITUXIMAB MAINTENANCE HAS CHANGED EVENT FREE SURVIVAL AND OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS USING GEMCITABINE AND OXALIPLATIN IN FIRST LINE THERAPY.. BLOOD: 54TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY, ASH, 2012 2012;120(21):-. 0.00 Y 0.00000 20160906 MD RU RU

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126789262 12678926 1 PS Rituximab RITUXIMAB 1 Intravenous (not otherwise specified) ON DAY 1 U 103705 375 MG/M**2 SOLUTION FOR INFUSION
126789262 12678926 2 SS METHOTREXATE. METHOTREXATE 1 Unknown 1000 MG/SQ.M/DAY ON DAY 2 U 0
126789262 12678926 3 SS CYTARABINE. CYTARABINE 1 Unknown ON DAYS 3-4 U 0 3000 MG/M**2 BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126789262 12678926 1 Mantle cell lymphoma
126789262 12678926 2 Mantle cell lymphoma
126789262 12678926 3 Mantle cell lymphoma

Outcome of event

Event ID CASEID OUTC COD
126789262 12678926 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
126789262 12678926 Acute kidney injury
126789262 12678926 Septic shock

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found